Product Description for CD85e / LILRA3
Rabbit anti Bovine, Human CD85e / LILRA3.
Presentation: Purified
Product is tested for Western blot / Immunoblot.
Presentation: Purified
Product is tested for Western blot / Immunoblot.
Properties for CD85e / LILRA3
| Product Category | Primary Antibodies |
|---|---|
| Quantity | 0.1 ml |
| Synonyms | CD85 antigen-like family member E, HM43/HM31, ILT-6, ILT6, Immunoglobulin-like transcript 6, LILRA3, LIR-4, LIR4, Leukocyte immunoglobulin-like receptor 4, Leukocyte immunoglobulin-like receptor subfamily A member 3, Monocyte inhibitory receptor HM43/HM31 |
| Presentation | Purified |
| Reactivity | Bov, Hu |
| Applications | WB |
| Clonality | Polyclonal |
| Host | Rabbit |
| Isotype | IgG |
| Shipping to | Europe, USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | OriGene Technologies, Inc. |
Datasheet Extract
| Immunogen |
|
|---|---|
| Application | WB |
| Background | Leukocyte Ig-like receptors (LIRs) are a family of immunoreceptors expressed predomintly on monocytes and B cells and at lower levels on dendritic cells and tural killer (NK) cells. All LIRs in subfamily B have an inhibitory function. LIRs in subfamily A, with short cytoplasmic domains lacking an immunoreceptor tyrosine-based inhibitory motif (ITIM) and with transmembrane regions containing a charged arginine residue, may initiate stimulatory cascades. One member of subfamily A (LILRA3) lacks a transmembrane region and is presumed to be a soluble receptor. |
| Format |
|
Accessory Products
Proteins and/or Positive Controls
Proteins for CD85e / LILRA3 (4 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| TP307003 |
CD85e / LILRA3 |
||||||
|
Human |
> 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|||
| OriGene Technologies, Inc. | |||||||
| TP721110 |
CD85e / LILRA3 (transcript variant 1) |
||||||
|
Human |
> 95 % Preparation: . Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
10 µg /
€299.00
|
|||
| OriGene Technologies, Inc. | |||||||
| H00011026-Q01-10 |
CD85e / LILRA3 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
| H00011026-Q01-25 |
CD85e / LILRA3 |
||||||
|
Human | Purified | 12.5% SDS-PAGE Stained with Coomassie Blue. | ||||
| Abnova Taiwan Corp. | |||||||
Positive controls for CD85e / LILRA3 (5 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00011026-T01 |
LILRA3 293T Cell Transient Overexpression Lysate(Denatured) |
||||||
![]() |
|||||||
| Abnova Taiwan Corp. | |||||||
| L131T6 |
LILRA3 / CD85e Lysate (Non-Denatured) |
||||||
![]() |
Transient overexpression cell lysate was tested with Anti-LILRA3 antibody (H00011026-M01) by Western Blots. | ||||||
| Abnova Taiwan Corp. | |||||||
| NBL1-12525 |
LILRA3 Lysate |
||||||
![]() |
|||||||
| Novus Biologicals Inc. | |||||||
| LY416372 |
LILRA3 overexpression lysate |
||||||
![]() |
0.1 mg /
€295.00
|
||||||
| OriGene Technologies, Inc. | |||||||
| LY432960 |
LILRA3 overexpression lysate |
||||||
![]() |
0.1 mg /
€315.00
|
||||||
| OriGene Technologies, Inc. | |||||||
Recommended Secondary Antibodies for CD85e / LILRA3 (9 products)
| Catalog No. | Host | Clone/Iso. | Pres. | React. | Applications | ||
|---|---|---|---|---|---|---|---|
| R1364AP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | AP | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364B |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | Biotin | Rb | E, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364F |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | FITC | Rb | E, ICC/IF, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364HRP |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | HRP | Rb | E, P, WB | |||
| OriGene Technologies GmbH | |||||||
| R1364T |
Rabbit IgG (H+L chain) antibody |
||||||
|
Goat | TRITC | Rb | E, F, ICC/IF | |||
| OriGene Technologies GmbH | |||||||
| R1427R |
Rabbit IgG F(ab)2 Fragment (H+L chain) antibody |
||||||
|
Donkey | PE | Rb | F | |||
| OriGene Technologies GmbH | |||||||
| R1458C2 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy2 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C3 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy3 | |||||
| OriGene Technologies GmbH | |||||||
| R1458C5 |
Rabbit IgG (H+L chain, adsorbed) antibody |
||||||
|
Goat | Cy5 | |||||
| OriGene Technologies GmbH | |||||||
![Western Blot: LILRA3 Lysate [NBL1-12525] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for LILRA3.](https://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/LILRA3%20Lysate-Western%20Blot-NBL1-12525-img0001.jpg)
